Dark circle
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Age 20-75 years, male or female, with a diagnosis of pigmented dark circles; (2) Fitzpatrick skin typing of Type II to IV; (3) Subjects agreed to participate in this study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Pregnancy or lactation; (2) Those with keloid body; (3) Those who have undergone skin rejuvenation treatments such as intense light, chemical peeling and laser within 6 months; (4) Those who have undergone botulinum toxin A treatment and filler treatment within 6 months; (5) Combined active psoriasis, vitiligo and other people prone to homoeopathic reactions; (6) Those who have combined severe cardiac, hepatic and renal insufficiency, coagulation disorders, platelet disorders and receive anticoagulation therapy; (7) Those with localized skin infections or excessive expectations of treatment; (8) Those with mental illness; (9)Other subjects deemed by the investigator to be unsuitable for participation in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Using VISIA skin detector to measure changes in facial skin values before and after treatment;Using a CK system to measure changes in facial parameters before and after treatment;Using a 3D system to measure changes in facial parameters before and after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain level;Patient satisfaction; | — |
Countries
China
Contacts
The First Affiliated Hospital, the Air Force Medical University